Core Viewpoint - The brain-computer interface (BCI) concept stocks surged on the first trading day of 2026 in the A-share market, driven by significant developments in the industry, including Neuralink's plans for mass production of BCI devices and supportive policies for high-end medical devices [1][3]. Group 1: Stock Performance - Multiple BCI-related stocks, including Aipeng Medical, Xiangyu Medical, and Meihua Medical, reached their daily limit up, with Aipeng Medical rising by 20% to 33.30 CNY [2][1]. - Other notable performers included Sainuo Medical and Hanwei Technology, which saw increases of 17.31% and 15.99%, respectively [2][1]. - The overall trend in the Hong Kong market mirrored that of the A-share market, with stocks like Nanjing Panda Electronics rising over 30% [2][1]. Group 2: Industry Developments - Elon Musk's Neuralink announced plans to begin large-scale production of BCI devices in 2026, signaling a significant advancement in the field [3]. - The integration of artificial intelligence in healthcare is accelerating, with 207 AI medical devices expected to be approved by 2025, highlighting the rapid technological progress [3]. - The global BCI market is projected to reach $12.4 billion by 2034, with a compound annual growth rate (CAGR) of 17% from 2025 to 2034, indicating substantial growth potential [3]. - Recent policy support, including the inclusion of implantable BCI devices in a priority approval list by the National Medical Products Administration, is expected to further enhance the commercialization process [3].

据新华社旧金山电，埃隆·马斯克2025年12月31日通过社交平台发布重磅消息，旗下脑机接口公司 Neuralink计划于2026年启动脑机接口设备大规模量产，并同步推出全自动化外科手术流程。这一规划标 志着脑机接口技术从临床验证阶段向产业化落地迈出关键一步，也成为A股人脑工程板块的强力催化， 截至1月5日上午收盘，该板块指数大涨12.56%至6245.59点，超十只概念股收获"20CM"涨停。 据Neuralink官网及马斯克公开发言内容，截至2025年9月份，该公司已完成12例脑机接口设备人体植入 手术，临床试验参与者累计使用设备时长超1.5万小时，患者可通过意念实现光标操控、文字输入甚至 机械臂辅助进食等操作，设备实际运行稳定性达标率超98%。同时，第二代手术机器人实现技术升级， 将单根电极植入时间从17秒压缩至1.5秒，整体手术时长从6小时缩短至20分钟内；成本端也实现大幅下 降，单台设备植入成本从早期百万美元级降至10万美元以内，全自动化手术落地后有望进一步下探至5 万美元区间。 《证券日报》记者注意到，A股相关上市公司早已在脑机接口赛道展开布局，从设备研发到临床应用多 维度切入，试图抢占行业发展先机 ...

Market Overview - The A-share market saw a strong opening on January 5, with the Shanghai Composite Index returning to 4000 points, closing at 4011.45, up 1.07% [1] - The Shenzhen Component Index rose by 1.87%, and the ChiNext Index increased by 2.15% [1] Trading Volume - The total trading volume in the Shanghai and Shenzhen markets reached 1.64 trillion yuan, an increase of 323.8 billion yuan compared to the previous trading day [3] Stock Performance - A total of 4064 stocks rose, with 99 stocks hitting the daily limit, while 1236 stocks declined [3] - The sectors that performed well included insurance, medical devices, semiconductors, and gaming, with brain-computer interface concept stocks experiencing significant gains [3] Sector Highlights Brain-Computer Interface - Brain-computer interface stocks surged, with several companies hitting the daily limit [6] - Notable performers included Xiangyu Medical, Guanhao Biological, Meihua Medical, Aipeng Medical, and Lepu Medical, all recording a 20% increase [6][7] - Elon Musk's Neuralink announced plans for large-scale production of brain-computer interface devices by December 31, 2026, which is expected to revolutionize the field by reducing invasiveness [9] Semiconductor Sector - The semiconductor sector also showed strength, with multiple stocks reaching their daily limit [10] - Key performers included Dongwei Semiconductor and *ST Tianlong, both achieving a 20% increase [11] - TSMC announced it received U.S. government approval to import chip manufacturing equipment to its Nanjing facility in 2026, which is a positive development for the sector [12] Insurance Sector - The insurance sector experienced a rally, with significant gains from major companies [13] - Xinhua Insurance rose by 7.53%, China Pacific Insurance by 6.16%, and China Life Insurance by over 5% [13][14] - The insurance industry reported a total premium income of 57.629 billion yuan for the first 11 months of 2025, a year-on-year increase of 7.6% [14]

Market Performance - On January 5, 2026, the A-share market opened strongly, with the Shanghai Composite Index returning to 4000 points after 34 trading days, closing at 4011 points with an increase of over 1% [1] - The Shenzhen Component Index and the ChiNext Index rose by 1.87% and 2.15% respectively, with over 4000 stocks in the market experiencing gains [1] Brain-Computer Interface Sector - The brain-computer interface sector showed significant activity, rising over 13% by midday, with key stocks such as Beikang reaching a 30% limit up, and others like Sanbo Brain Science, Aipeng Medical, and Dineke hitting 20% limit up [1] - Elon Musk announced that his brain-computer interface company, Neuralink, plans to begin large-scale production of brain-computer interface devices in 2026, transitioning to a more streamlined and nearly fully automated surgical process [1] Aerospace and Precious Metals - In the commercial aerospace sector, stocks like Huazhu Gaoke and Feiwo Technology saw increases of 13.87% and 12.95% respectively, while Aerospace Hanyu rose over 10% [1] - In the precious metals sector, Hunan Silver and Hunan Gold increased by 9.68% and 2.7% respectively [1] - In the smart medical field, stocks such as Kefu Medical, Guhan Medicine, and Dahu Co. rose over 6% [1]

【导读】上午A股三大指数集体大涨，半导体、保险板块大涨，脑机接口概念股掀"涨停潮" 大家好，今天是2026年第一个交易日，基金君和你继续关注市场行情！ 1月5日上午，A股三大股指高开高走，沪指重返4000点，超4000只个股上涨，近百只个股涨停。截至午间收盘，沪指报4011.45点，涨1.07%，深证成指涨 1.87%，创业板指涨2.15%。 沪深两市半日成交额达1.64万亿元，较上个交易日放量3238亿元。个股涨多跌少，全市场共4064只个股上涨，99只个股涨停，有1236只个股下跌。 个股方面，翔宇医疗、冠昊生物（300238）、美好医疗（301363）、爱朋医疗（300753）、乐普医疗（300003）录得20cm涨停，三七互娱（002555）、 创新医疗（002173）、航天长峰（600855）录得10cm涨停。 | 代码 | 名称 | 现价 | 涨跌幅 ▼ | 总市值1 | 年初至今涨跌幅 | | --- | --- | --- | --- | --- | --- | | 688626 | 翔宇医疗 | 72.60 | 20.00% | 116亿 | 20.00% | | 300238 | 冠昊生物 ...

脑机接口概念股集体暴涨。 公历2026年首个交易日（1月5日）上午，A股市场强劲上行，其中上证指数向上突破4000点整数大关。 在上周五（1月2日）大涨后，上午港股市场涨势趋缓。 值得注意的是，受到相关消息提振，上午A股市场和港股市场的脑机接口概念股集体暴涨，相关个股掀涨停潮。 沪指冲上4000点 公历2026年首个交易日上午，A股市场强劲上行，主要指数不同程度上涨，截至中午收盘，上证指数涨超1%，报4011.45点，再次站上4000点整数大关； 深证成指涨近2%。 创业板和科创板走势抢眼，其中科创50指数涨超4%，创业板指涨超2%。 行业板块和赛道方面，若按照申万一级行业划分，电子板块领涨，板块盘中涨幅超过3%，板块内个股掀起涨停潮。东微半导、云汉芯城盘中20%涨停， 江波龙、上海新阳、矽电股份等多股盘中涨幅超过10%，可川科技、盈趣科技等股票盘中涨停。 医药生物板块涨幅亦居前，板块盘中涨幅超过3%，板块内个股亦掀起涨停潮。三博脑科、爱朋医疗、迈普医学、伟思医疗、翔宇医疗等多股盘中20%涨 停，另有多股涨停或涨幅超过10%。 非银金融板块亦领涨市场，板块涨幅超过2%，其中保险股走势强劲。新华保险涨幅超过7% ...

Core Viewpoint - The A-share market experienced a significant surge on January 5, 2026, driven by the brain-computer interface (BCI) sector, with the index rising over 12% and multiple stocks hitting their daily limit up [1] Group 1: Market Performance - On the opening day of the A-share market, stocks related to brain-computer interfaces saw a collective rally, with stocks like BeiYikang (920199.BJ) hitting a 30% limit up and others such as Botao Bio (688767.SH) and Sanbo Neuroscience (301293.SZ) reaching 20% limit up [1] - A total of 11 stocks in the BCI sector experienced a 20% limit up, indicating strong investor interest and market momentum [1] Group 2: Technological Developments - The surge in the BCI sector was catalyzed by news of mass production of BCI devices by Elon Musk's company, Neuralink, expected to begin in 2026, which includes advancements in surgical procedures [1] - Neuralink's device will feature electrodes that can penetrate the dura mater without removal, marking a significant technological breakthrough [1] Group 3: Domestic Developments - In China, several companies are emerging that parallel Neuralink's technological approach, with Guotai Junan Securities declaring 2025 as the year for clinical trials of invasive and semi-invasive BCIs [2] - Companies like Borui Kang have completed clinical trials, with expectations for regulatory approval in 2026, while other firms are also making progress in BCI technology [2] Group 4: Market Projections - Open Source Securities predicts that BCI technology will redefine human-robot interaction and is expected to commercialize by 2026, expanding from medical applications to AI and robotics [3] - The global BCI market is projected to grow to approximately $12.4 billion by 2034, with a CAGR of 17% from 2025 to 2034, indicating strong future growth potential [3]

2026年A股首个交易日，市场一片热闹景象。 一方面，上证指数再度站上4000点，日线迎来罕见的12连阳。另一方面，权重股搭台，个股普涨，热点全面开花。 权重股方面，保险板块大涨；此外，贵州茅台（600519）、宁德时代（300750）、中芯国际等龙头股均上涨。板块方面，脑机接口、医药、半导体、消费 电子等板块大涨。 截至上午收盘，上证指数上涨1.07%，报4011.45点；深证成指上涨1.87%，创业板指上涨2.15%。 | 新华保险 融 601336 | 74.95 | 7.53% | 1563 Z | | --- | --- | --- | --- | | 中国太保 | 44.49 | 6.16% | 3045亿 | | 融 601601 | | | | | 行业龙头3 | | | | | 中国平安 ■ 601318 | 72.20 | 5.56% | 7697亿 | | 行业龙头2 | | | | | 中国人寿 融 601628 | 47.85 | 5.16% | 9964 Z | | 行业龙头1 | | | | | 中国人保 融 601319 | 9.38 | 4.80% | 3330亿 | 202 ...

Group 1 - The Shanghai Composite Index closed at 4011.45 points, above the six-month moving average, with an increase of 1.07% [1] - The total trading volume of A-shares reached 1,960.478 billion yuan [1] - A total of 265 A-shares have surpassed the six-month moving average, with notable stocks showing significant deviation rates [1] Group 2 - The stocks with the highest deviation rates include BeiYikang (19.09%), *ST HuiKe (18.48%), and WeiSi Medical (18.24%) [1] - Other stocks that have just crossed the six-month moving average include ChuanHua ZhiLian, YueDa Investment, and ChuangYao Technology, with smaller deviation rates [1] - The trading performance of stocks on January 5 shows significant increases, with several stocks achieving over 20% gains [1][2]

Group 1 - Major market indices opened higher on the first trading day of 2026, with electronics and media sectors rising over 2%, while pharmaceuticals and non-bank financials also showed strong gains [1] - The brain-computer interface (BCI) concept surged, with the index rising over 10%, leading to a wave of stock price increases, including a 30% limit up for BeiYikang and 20% limit ups for Sanbo Brain Science, Meihao Medical, and Aipeng Medical [2] - Elon Musk announced that his BCI company Neuralink will start large-scale BCI output in 2026, planning to shift towards nearly fully automated surgeries [3] Group 2 - Open Source Securities reported that Neuralink's expectations for scaled production and automated surgical solutions signify a transition from clinical validation to commercial scalability for brain-computer interfaces [4] - Companies with positive earnings forecasts for 2025 have performed well, with C Strong rising over 10% and Salt Lake Shares and Ocean Biological both increasing over 7%. Over 40 companies have released earnings forecasts, with many expecting profit increases, including Transfar Zhilian, Baiao Saitu, and Tianci Materials, all projecting profit growth exceeding 100% [5] - Ocean Biological expects a net profit growth of 50.6% to 72.56 million for 2025 [5] Group 3 - Two new stocks are available for subscription this week, including Zhixin Co., which specializes in automotive welding parts and has become a primary supplier for major automotive manufacturers [7] - Kema Materials focuses on the research, production, and sales of dry friction plates and wet paper-based friction plates, aiming to develop new friction materials [8] Group 4 - As of December 31, 2025, the market's financing balance totaled 2.52 trillion, a decrease of 143.69 billion from the previous trading day [9] - 349 stocks received net financing purchases exceeding 10 million, with 34 stocks having net purchases over 1 billion [10] - China Satellite topped the list with a net purchase of 1.194 billion, followed by Xinwei Communication and Aerospace Electronics with net purchases of 525 million and 499 million, respectively [11]